Dow Up 1.65% Nasdaq Up 1.76%

Alimera Sciences, Inc. (ALIM)

-NasdaqGM
5.17 Up 0.36(7.48%) 11:14AM EDT - Nasdaq Real Time Price
Prev Close:4.81
Open:4.86
Bid:5.20 x 400
Ask:5.21 x 100
1y Target Est:10.00
Beta:2.19
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.84 - 5.23
52wk Range:1.76 - 8.44
Volume:752,035
Avg Vol (3m):278,717
Market Cap:208.98M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALIM

Comparison

Symbol% ChgMkt Cap
ALIMUp 7.48%208.98M
AGNUp 1.36%55.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.36
Quarterly EPS Est (Sep-14) :-0.70
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback